CR Pharmaceutical and NAMI collaborate to explore palbociclib’s potential for Alzheimer’s treatment, leveraging ...

Boston, USA-based Verastem Oncology today announced the appointment of Matthew Ros as chief operating officer (COO). In his ...

US clinical-stage pharma Keros Therapeutics today announced that it has voluntarily halted all dosing in the TROPOS trial, a ...

Eli Lilly saw its shares close down 6.6% at $744.91 yesterday, after it revealed forecast for sales at the JP Morgan ...

Cases of avian influenza A (H5N1) continue to rise among cattle and humans in the USA. Scientists and government health ...

Belgian drugmaker UCB has presented what it calls its ‘growth journey’ and the strategic priorities driving future success at ...

Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a ...

Shares of US biotech Regenxbio surged 18.4% in pre-open trading Tuesday after announced a strategic partnership with Japan’s ...

Several of the USA’s biggest pharmacy benefit managers (PBMs) have generated billions of dollars in revenue by charging ...

Japanese drugmaker Daiichi Sankyo announced that it will pay Glycotope GmbH $132.5 million to acquire intellectual property ...

Verastem Oncology licenses VS-7375 rights from GenFleet Therapeutics, aiming to target KRAS-driven cancers. Early Phase I ...

Mabwell Bioscience plans a secondary listing in Hong Kong to bolster development and global expansion. The move targets Hong ...